Evaxion Biotech Concludes Large Non-rodent Animal Infection Studies, Testing Antigens From Evaxion's Preclinical EVX-b1 Vaccine Candidate Against Staphylococcus Aureus, Studies Showed EVX-b1 Antigens Significantly Reduced Disease Burden
Evaxion Biotech完成了大型非齧齒動物感染研究,測試了Evaxion針對金黃色葡萄球菌的臨床前eVx-B1候選疫苗的抗原,研究表明 eVx-B1 抗原顯著減輕了疾病負擔